For all mankind.
For men, low testosterone is a global health concern. Approximately 40% of men over the age of 45 have low testosterone. It’s no myth testosterone deficiency affects male sexuality, reproduction, general health, and quality of life. The good news is that we can treat it — simply, safely, and effectively. It’s been proven when men maintain a healthy balance of testosterone it not only improves symptoms of aging but protects against obesity, diabetes, heart disease and ultimately leads to a longer life.
Restoring your testosterone levels to an ideal level usually takes about two to four weeks. Testosterone replacement has been shown to improve energy, libido, erections and decrease body fat. Going further, it is also known to combat minor depression, increase bone density, and improve muscle mass. Plus, it can be beneficial for memory and cardiac performance. READ MORE >
The testosterone pellet.
The most effective dosing that is very consistent and proven to reduce the risk of elevated blood counts is testosterone pellet injections. These are tiny pellets are about the size of a grain of rice that are placed under the skin and dissolve slowly over several months. They do not need to be removed and are generally inserted 2-3 times per year.
What to expect at Allure.
During your visit, you will answer a questionnaire and have blood work done. An appointment will be scheduled in two weeks to review the laboratory results and go over a plan. When the pellets are inserted, you will have a small bandage that can be removed in a couple of days. Pellets are generally placed in the buttocks but can go anywhere. Symptom improvement generally takes 2-3 weeks. Additional lab monitoring is fairly infrequent. As noted, the absolute level of testosterone is not an accurate predictor of deficiency or excess, it is more symptom-based.
Make a commitment to feel better.
To book an appointment or request more information from one of our HRT specialists email us at email@example.com.
Fundamental Concepts Regarding Testosterone Deficiency and Treatment: International Expert Consensus Resolutions.
Mayo Clinic Proceedings July 2016;91(7):881-896
In this summary of the International Society for the Study of the Aging Male, the participants for these resolutions were from a broad range of specialties, 11 countries, and 4 continents.
1. Testosterone deficiency is a well-established, significant medical condition which negatively affects male sexuality, reproduction, general health, and quality of life.
Low testosterone can predict an increased risk of obesity or metabolic syndrome. Low testosterone is associated with increased death rate and more cardiovascular events and deaths. It is also associated with lower quality of life and poor general health.
2. The symptoms and signs of testosterone deficiency occur as a result of low levels of testosterone and may benefit from treatment regardless of whether there is an identified underlying etiology.
This means that, regardless of the cause of low testosterone, men benefit from testosterone replacement. They additionally point out that it is inappropriate to withhold testosterone replacement when a cause cannot be identified, which is usually the case.
3: Testosterone deficiency is a global health problem.
In the study, they explain the enormous costs (in the hundreds of billions of dollars in the US alone)
4: Testosterone therapy for men with testosterone deficiency is an effective, rational, and evidence-based.
- Testosterone replacement definitively benefits sexual desire as well as erectile and orgasmic function.
- Testosterone improves bone mineral density, mood, and energy.
5: There is no testosterone concentration threshold that reliably distinguishes those who will respond to treatment from those who will not.
In this resolution, the consensus agreed unanimously that the absolute value of testosterone on a blood test is not a predictor or an accurate way to diagnose testosterone deficiency. Symptoms of testosterone deficiency, as well as the overall clinical picture are combined with laboratory evaluation to assist in decision making for testosterone replacement.
6: There is no scientific basis for any age-specific recommendations against the use of testosterone therapy in men.
Men, regardless of age, responded to testosterone therapy when they were deficient. Age is not a predictor of testosterone deficiency, and other factors such as genetics, overall health and obesity play roles in testosterone deficiency.
Avoiding testosterone replacement in elderly men is as illogical as avoiding the treatment of other conditions such as high blood pressure, heart disease, arthritis and cancer because they occur more frequently as men age.
7: The evidence does not support increased risks of cardiovascular events with testosterone therapy.
- Numerous clinical studies have shown benefits in replacing testosterone in men with heart diseases, such as greater exercise capacity and less chest pain.
- Low testosterone is known to be associated with increased heart disease, obesity, and mortality.
- There were two recent reports of testosterone replacement possibly having a negative impact on cardiovascular health. These reports were flawed and were not supported by numerous other positive studies on testosterone replacement.
8: The evidence does not support increased risk of prostate cancer with testosterone therapy.
Testosterone therapy does not increase the risk of prostate cancer. Men previously treated for prostate cancer, and in remission, can safely use testosterone replacement.
9: The evidence supports major research initiative to explore possible benefits of testosterone therapy for a cardiometabolic disease, including diabetes.
- Men with low testosterone who receive testosterone therapy have ½ the mortality rate of untreated men.
- Men treated with testosterone therapy have less cardiovascular events and death than men not treated.
- Testosterone therapy reliably increases lean body mass and decreases fat mass.
- Higher levels of testosterone are protective to the heart and cardiovascular system.